About Biopredic Advancells
Biopredic Advancells is a company based in Noida (India) founded in 2019 by Vipul Jain. It operates as a B2B. Biopredic Advancells offers products and services including Primary Cells, HepaRG™ Cell Line, and Tissues and Fluids. Biopredic Advancells operates in a competitive market with competitors including Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.
- Headquarter Noida, India
- Founders Vipul Jain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biopredic Advancells Private Limited
- Date of Incorporation 01 Aug, 2019
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$86.43 K (USD)152.16as on Mar 31, 2022
-
Net Profit
$8.61 K (USD)111.74as on Mar 31, 2022
-
EBITDA
$9.39 K (USD)945.54as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biopredic Advancells
Biopredic Advancells offers a comprehensive portfolio of products and services, including Primary Cells, HepaRG™ Cell Line, and Tissues and Fluids.
Customized cells for drug research and toxicology studies.
Hepatic stem cell line for in vitro toxicology testing.
Samples for pharmacokinetics and biomarker studies.
Funding Insights of Biopredic Advancells
Detailed funding history for Biopredic Advancells
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biopredic Advancells
Investment portfolio details for Biopredic Advancells
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biopredic Advancells
Detailed financials for Biopredic Advancells
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biopredic Advancells Comparisons
Peer comparison for Biopredic Advancells
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biopredic Advancells
Biopredic Advancells operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| Locked | Locked | Locked |
3D cell culture products are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Metastatic cancer properties are targeted by Remedy Plan's containment therapy.
|
Detailed competitors of Biopredic Advancells
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biopredic Advancells
Complete news archive for Biopredic Advancells
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biopredic Advancells
Biopredic Advancells was founded in 2019.
Biopredic Advancells is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Annual revenue of Biopredic Advancells is $86.43K as on Mar 31, 2022.
Biopredic Advancells Pvt. Ltd., based in Noida, India, is a joint venture between French and Indian firms, specializing in biological solutions for translational medicine. They produce and distribute primary cells, cell lines, tissues, and reagents for drug development, toxicology, and cosmetics research. Serving academic institutions and industrial clients like CROs and pharmaceutical companies, they support in vitro studies to replace animal testing, ensuring cost-effective and replicable products.
Biopredic Advancells's top competitors include CytoTronics, Kiyatec and Remedy Plan.
Biopredic Advancells offers Primary Cells, HepaRG™ Cell Line, and Tissues and Fluids.